Chronic Myeloproliferative Disorders Completed Phase Trials for Sirolimus (DB00877)

IndicationStatusPhase
DBCOND0028462 (Chronic Myeloproliferative Disorders)CompletedNot Available
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00513474Rasburicase in Preventing Graft-Versus-Host Disease in Patients With Hematologic Cancer or Other Disease Undergoing Donor Stem Cell TransplantSupportive Care